DK1317254T3 - Retardpartikeldispersion - Google Patents

Retardpartikeldispersion

Info

Publication number
DK1317254T3
DK1317254T3 DK01971697T DK01971697T DK1317254T3 DK 1317254 T3 DK1317254 T3 DK 1317254T3 DK 01971697 T DK01971697 T DK 01971697T DK 01971697 T DK01971697 T DK 01971697T DK 1317254 T3 DK1317254 T3 DK 1317254T3
Authority
DK
Denmark
Prior art keywords
compositions
particle dispersion
retardant particle
preproducts
dose
Prior art date
Application number
DK01971697T
Other languages
English (en)
Inventor
Roland Bodmeier
Original Assignee
Bertex Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bertex Pharma Gmbh filed Critical Bertex Pharma Gmbh
Application granted granted Critical
Publication of DK1317254T3 publication Critical patent/DK1317254T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Silicon Polymers (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Paints Or Removers (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Fireproofing Substances (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DK01971697T 2000-09-05 2001-09-04 Retardpartikeldispersion DK1317254T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10044545A DE10044545A1 (de) 2000-09-05 2000-09-05 Retardpartikeldispersion
PCT/DE2001/003438 WO2002019988A2 (de) 2000-09-05 2001-09-04 Retardpartikeldispersion

Publications (1)

Publication Number Publication Date
DK1317254T3 true DK1317254T3 (da) 2007-06-25

Family

ID=7655571

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01971697T DK1317254T3 (da) 2000-09-05 2001-09-04 Retardpartikeldispersion

Country Status (9)

Country Link
US (1) US7820202B2 (da)
EP (1) EP1317254B1 (da)
AT (1) ATE355051T1 (da)
AU (1) AU2001291627A1 (da)
DE (3) DE10044545A1 (da)
DK (1) DK1317254T3 (da)
ES (1) ES2283433T3 (da)
PT (1) PT1317254E (da)
WO (1) WO2002019988A2 (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0996426B1 (de) * 1997-06-05 2007-03-07 Roland Bodmeier Multiphasensystem
US20050194060A1 (en) * 2004-03-03 2005-09-08 Vincent Houwaert Peelable seal closure assembly
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
PT1578422E (pt) 2002-12-20 2007-06-14 Niconovum Ab Material particulado contendo nicotina fisicamente e quimicamente estável
US20040191301A1 (en) * 2003-03-27 2004-09-30 Van Duren Albert Philip Transdermal device having a phase change material
WO2006078320A2 (en) 2004-08-04 2006-07-27 Brookwood Pharmaceuticals, Inc. Methods for manufacturing delivery devices and devices thereof
US8852638B2 (en) 2005-09-30 2014-10-07 Durect Corporation Sustained release small molecule drug formulation
AU2007224584A1 (en) 2006-03-16 2007-09-20 Niconovum Ab Improved snuff composition
US9004761B2 (en) 2006-05-01 2015-04-14 Baxter International Inc. Multiple chamber container with mistake proof administration system
TW200808375A (en) * 2006-05-12 2008-02-16 Otsuka Pharma Co Ltd Hydrogel suspension and manufacturing process thereof
ES2562878T3 (es) 2007-05-25 2016-03-08 Indivior Uk Limited Formulaciones de liberación sostenida de compuestos de risperidona
WO2009085952A1 (en) 2007-12-20 2009-07-09 Brookwood Pharmaceuticals, Inc. Process for preparing microparticles having a low residual solvent volume
CA2736531C (en) * 2008-09-17 2016-10-25 Modoral Brands Inc. Process for preparing snuff composition
US10137280B2 (en) 2011-06-30 2018-11-27 Incube Labs, Llc System and method for treatment of hemorrhagic stroke
US10130514B2 (en) 2011-09-26 2018-11-20 Incube Labs, Llc System and method for delivery of a therapeutic agent to the inner ear
DE102012221460A1 (de) * 2012-11-23 2014-06-12 Beiersdorf Ag Verwendung von Triethylcitrat als Vergällungsmittel für Ethanol
EA033537B1 (ru) 2013-03-11 2019-10-31 Durect Corp Инъекционная композиция с контролируемым высвобождением, содержащая жидкий носитель с высокой вязкостью
US20140308352A1 (en) 2013-03-11 2014-10-16 Zogenix Inc. Compositions and methods involving polymer, solvent, and high viscosity liquid carrier material
WO2021051080A1 (en) * 2019-09-13 2021-03-18 University Of Utah Research Foundation Opioid independent surgical anesthetic
US12414917B2 (en) 2019-09-13 2025-09-16 University Of Utah Research Foundation Opioid independent surgical anesthetic
CN115666621A (zh) 2020-01-13 2023-01-31 度勒科特公司 具有减少的杂质的持续释放药物递送系统及相关方法
CA3203561A1 (en) 2021-01-12 2022-07-21 Adrian Neil Verity Sustained release drug delivery systems and related methods

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4938763B1 (en) * 1988-10-03 1995-07-04 Atrix Lab Inc Biodegradable in-situ forming implants and method of producing the same
DE4122591C1 (en) * 1991-07-08 1993-02-18 Roland 8012 Ottobrunn De Bodmeier Producing microcapsules of water insoluble polymer and active agent - includes dissolving or dispersing active agent in aq. polymer contg. gellable assistants
AU2605592A (en) * 1991-10-15 1993-04-22 Atrix Laboratories, Inc. Polymeric compositions useful as controlled release implants
EP2283821A1 (en) * 1993-11-19 2011-02-16 Alkermes, Inc. Preparation of biodegradable microparticles containing a biologically active agent
US5785682A (en) * 1995-03-22 1998-07-28 Abbott Laboratories Pre-filled syringe drug delivery system
GB2310801A (en) * 1996-03-04 1997-09-10 Merck & Co Inc Process for removing an organic solvent from lactide-glycoside copolymer microspheres
US8226598B2 (en) * 1999-09-24 2012-07-24 Tolmar Therapeutics, Inc. Coupling syringe system and methods for obtaining a mixed composition
US6461631B1 (en) * 1999-11-16 2002-10-08 Atrix Laboratories, Inc. Biodegradable polymer composition

Also Published As

Publication number Publication date
US20030152634A1 (en) 2003-08-14
DE10193689D2 (de) 2003-08-07
EP1317254B1 (de) 2007-02-28
EP1317254A2 (de) 2003-06-11
AU2001291627A1 (en) 2002-03-22
DE10044545A1 (de) 2002-04-04
WO2002019988A2 (de) 2002-03-14
WO2002019988A3 (de) 2002-06-27
ES2283433T3 (es) 2007-11-01
DE50112128D1 (de) 2007-04-12
ATE355051T1 (de) 2006-03-15
PT1317254E (pt) 2007-06-05
US7820202B2 (en) 2010-10-26

Similar Documents

Publication Publication Date Title
DK1317254T3 (da) Retardpartikeldispersion
EG25544A (en) Solid redispersible emulsion
EP4356965A3 (en) Cannabinoid compositions and methods of preparation thereof
WO2005009389A3 (en) Anaplastic lymphoma kinase modulators and methods of use
TR200101822T2 (tr) Kontrollü salınan galantamin bileşimi
ATE395042T1 (de) Darreichungsformen welche mikropartikel und treibgas enthalten
MY147661A (en) Fused bicycloheterocycle substituted azabicyclic alkane derivatives
WO2002096361A3 (en) 5-aralkylsulfonyl-3- (pyrrol-2-ylmethylidene)-2-indolinone derivatives as kinase inhibitors
BG104693A (en) Fast melting oral dosage form
TN2009000398A1 (en) 5,6-dihydro-1h-pyridin-2-one compounds
MY146557A (en) Revaprazan-containing solid dispersion and process for the preparation thereof
EP1793827A4 (en) TRICYCLIC ANILID SPIROHYDANTOIN CGRP RECEPTOR ANTAGONISTS
WO2008107042A3 (en) Improved combustibility of a waste plastic based fuel source
MXPA03010158A (es) Sulfonamidas.
ATE500207T1 (de) Fettsäureanhydride enthaltende dispersionspulver
DE602006014601D1 (de) Harzverkapselter intensivsüsstoff
ATE293964T1 (de) Zusammensetzungen und verfahren zur behinderung der entladung von nematokyste
PL1677818T3 (pl) Stabilne kompozycje wodne zawierające G-CSF
TW200640459A (en) Particulate-stabilized injectable pharmaceutical compositions of posaconazole
ATE378038T1 (de) Mikroemulsionen und ihre verwendung zur prävention von erkrankungen der atemwege
UA95088C2 (ru) Композиция, которая содержит наночастички связанные с биосовместимым полимером противоракового агента и снижает аллопецию при химиотерапии, способ ее получения
PT1177223E (pt) Dispersoes de plastico aquosas que apresentam uma estabilidade mais elevada
TW200727909A (en) Enterokinesis promoting ingesta
MX2007001463A (es) Composiciones de anti-espuma que contienen acidos grasos y de colofonia o derivados de los mismos.
WO2006030301A8 (en) Cilostazol- containing pharmaceutical composition based on particles of less than 50 micrometers